Brian Goodman, CEO of Golden Matrix Group Inc. explains how they stay one step ahead of their rivals. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.60
Bid: 1.50
Ask: 1.70
Change: 0.00 (0.00%)
Spread: 0.20 (13.333%)
Open: 1.60
High: 1.60
Low: 1.60
Prev. Close: 1.60

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares and TVR

30 Nov 2023 07:00

RNS Number : 1977V
Seed Innovations Limited
30 November 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

30 November 2023

SEED Innovations Limited

("SEED" or the "Company")

Transaction in Own Shares & TVR

SEED Innovations Ltd, the AIM-quoted company investment company providing shareholders with exposure to early-stage health, wellness and medical cannabis companies to which, in normal circumstances, they have limited access to, announces that it has purchased the following number of its shares of 1p each on the London Stock Exchange to be held in treasury (through Shard Capital Stockbrokers Limited ("Shard") acting as the Company's broker).

Date of Purchase

29 November 2023

Number of shares purchased (aggregated volume):

100,000

Highest price paid per share (pence):

2.3222 pence

Lowest price paid per share (pence):

2.3222 pence

Volume weighted average price paid per share (pence):

2.3222 pence

 

Following the purchase of these shares, the Company's issued ordinary share capital consists of 215,219,841 ordinary shares of which a total of 9,682,446 shares are held in treasury. The remaining 205,537,395 shares represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Shard on 29 November 2023 as part of the Programme as defined by the Company in the announcement on 29 September 2023.

Aggregate information: 

Venue

Volume-weighted average price (pence per share)

Aggregated volume

AIMX

2.3222

100,000

 

 

 

 

 

 

Individual transactions:

Number of shares purchased

Transaction price(pence per share)

Time of transaction

Venue

100,000

2.3222

10.06.42

AIMX

 

-Ends-

For further information on the Company please visit: www.seedinnovations.co or contact: 

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: info@seedinnovations.co 

 

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Catherine Leftley

Ana Ribeiro

Isabelle Morris

 

St Brides Partners Ltd,

Financial PR

E: seed@stbridespartners.co.uk

Notes

Seed Innovations Ltd

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFDISMSEDSEIF
Date   Source Headline
27th Jun 20237:00 amRNSFinal Results
12th Jun 20238:07 amRNSPortfolio Company Update: Northern Leaf Limited
1st Jun 20237:00 amRNSInvestee Company Update: Little Green Pharma Ltd
17th May 202312:50 pmRNSInvestee Company Update: Avextra
9th May 20231:37 pmRNSInvestee Company Update: Yooma Wellness Inc.
9th May 20239:45 amRNSInvestee Company Update: Little Green Pharma Ltd
27th Apr 202312:35 pmRNSInvestee Company Update: Little Green Pharma Ltd
24th Apr 20237:00 amRNSPortfolio Update: Northern Leaf CLN conversion
20th Apr 202310:01 amRNSSale of South West Brands to OTO for £6.2 million
17th Apr 202311:19 amRNSInvestee Company Update: Little Green Pharma LTD
11th Apr 20237:00 amRNSLeap Gaming Update – Offer Declared Unconditional
24th Mar 202311:04 amRNSInvestee Company Update: Little Green Pharma Ltd
22nd Mar 202310:26 amRNSInvestee Company Update: Little Green Pharma Ltd
22nd Mar 202310:25 amRNSInvestee Company Update: Little Green Pharma Ltd
15th Mar 202312:45 pmRNSAvextra AG Successfully Raises EUR 17 million
21st Feb 20237:00 amRNSPortfolio Company Update: South West Brands
15th Feb 202310:45 amRNSInvestee Company Update: Little Green Pharma Ltd
13th Feb 20233:00 pmRNSInvestee Company Update: Yooma Wellness Inc.
9th Feb 20237:15 amRNSInvestee Company Update: Avextra
6th Feb 20232:45 pmRNSInvestee Company Update: Little Green Pharma Ltd
16th Jan 20232:30 pmRNSInvestee Company Update: Little Green Pharma Ltd
4th Jan 20232:15 pmRNSDirector Share Purchase
15th Dec 20224:22 pmRNSDirector Share Purchase
14th Dec 20224:07 pmRNSDirector Share Purchases
12th Dec 20225:22 pmRNSInterim Results
7th Dec 20227:00 amRNSEUR14 million Offer for Leap Gaming
5th Dec 20227:00 amRNSInvestee Company Update: Clean Food Group Ltd
2nd Dec 202210:00 amRNSInvestee Company Update: Little Green Pharma Ltd
1st Dec 20227:00 amRNSInvestee Company Update: Little Green Pharma Ltd
11th Nov 202210:15 amRNSPortfolio Company Update: South West Brands
2nd Nov 20221:20 pmRNSInvestee Company Update: Little Green Pharma
4th Oct 202212:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
4th Oct 20227:30 amRNSInvestee Company Update: Avextra
16th Sep 20229:03 amRNSEurox – Change of Name to Avextra
7th Sep 20224:00 pmRNSResult of AGM & Updated Investor Presentation
2nd Sep 20222:50 pmRNSPortfolio Valuation Update & Investor Presentation
9th Aug 20227:00 amRNSNotice of AGM & Investor Presentation
8th Aug 20227:00 amRNSFurther Investment in South West Brands Limited
1st Aug 20227:00 amRNSNew Investment: Clean Food Group Ltd
21st Jul 20227:00 amRNSFinal Results
12th Jul 202212:10 pmRNSInvestee Company Update: Little Green Pharma Ltd
1st Jul 20225:30 pmRNSInvestee Company Update: Little Green Pharma Ltd
8th Jun 20223:05 pmRNSLoan to Portfolio Company, Leap Gaming
25th May 20222:08 pmRNSInvestee Company Update: Yooma Wellness Inc.
24th May 20227:00 amRNSInvestee Company Update: Leap Gaming
19th May 20227:00 amRNSInvestee Company Update - Little Green Pharma
18th May 20224:20 pmRNSInvestee Company Update: Yooma Wellness Inc.
4th May 20224:01 pmRNSInvestee Company Update: Yooma Wellness Inc.
3rd May 20227:00 amRNSInvestee Company Update - Little Green Pharma
19th Apr 20221:00 pmRNSInvestee Company Update: Little Green Pharma

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Free Investment Tools

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.